Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Gyre Therapeutics (GYRE) Gross Profit (2020 - 2026)

Gyre Therapeutics has reported Gross Profit over the past 6 years, most recently at $13.4 million for Q4 2025.

  • Quarterly Gross Profit fell 49.88% to $13.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $89.1 million through Dec 2025, down 12.54% year-over-year, with the annual reading at $51.4 million for FY2025, 49.54% down from the prior year.
  • Gross Profit was $13.4 million for Q4 2025 at Gyre Therapeutics, down from $28.9 million in the prior quarter.
  • Over five years, Gross Profit peaked at $97.5 million in Q4 2022 and troughed at -$14000.0 in Q4 2021.
  • The 5-year median for Gross Profit is $24.5 million (2024), against an average of $22.1 million.
  • Year-over-year, Gross Profit tumbled 100.93% in 2021 and then skyrocketed 696535.71% in 2022.
  • A 5-year view of Gross Profit shows it stood at -$14000.0 in 2021, then skyrocketed by 696535.71% to $97.5 million in 2022, then tumbled by 73.44% to $25.9 million in 2023, then increased by 3.08% to $26.7 million in 2024, then tumbled by 49.88% to $13.4 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Gross Profit are $13.4 million (Q4 2025), $28.9 million (Q3 2025), and $25.6 million (Q2 2025).